ABOUT THIS EVENT
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Brian Wong, M.D., Ph.D., President & CEO, rang the Opening Bell.